The Wake Forest Institute for Regenerative Medicine (WFIRM) has been awarded a major eight-year, $48 million research funding award from the U.S. Department of Health and Human Services (HHS) to ...
Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare agent A ...